The effects of the histone deacetylase inhibitor 4-phenylbutyrate on gap junction conductance and permeability

Frontiers in Pharmacology

Volumn 4 SEP, Issue , 2013, Pages

  Kaufman, Joshua ^a   Gordon, Chris ^a   Bergamaschi, Roberto ^a   Wang, Hong Z ^a   Cohen, Ira S ^a   Valiunas, Virginijus ^a   Brink, Peter R ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

4 phenylbutyrate; Conductance; Connexin43; Gap junction; Permeability

Indexed keywords

4 PHENYLBUTYRIC ACID; CONNEXIN 43; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR;

ARTICLE; CELL MEMBRANE PERMEABILITY; CELL STRAIN HEK293; CONTROLLED STUDY; ENZYME INHIBITION; GAP JUNCTION; GENETIC TRANSFECTION; HEART MUSCLE FIBER MEMBRANE CONDUCTANCE; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HELA CELL; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; MEMBRANE CHANNEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION;

EID: 84885362623     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2013.00111     Document Type: Article

References (20)

1. Asklund, T., Appelskog, I., Appelskog, I. B., Ammerpohl, O., Ekstrom, T. J., and Almqvist, P. M. (2004). Histone deacetylase inhibitor 4-phenylbutyrate modulates glial fibrillary acidic protein and connexin 43 expression and enhances gap junction communication, in human glioblastoma cells. Eur. J. Cancer 40, 1073-1081. doi:10.1016/j.ejca.2003.11.034.
2. Brink, P., Ramanan, S., and Christ, G. (1996). Human connexin 43 gap junction channel gating:evidence for mode shifts and/or heterogenicity. Am. J. Physiol. 271, 321-331.
3. Bukauskas, F. F., Jordan, K., Bukauskiene, A., Bennett, M. V. L., Lampe, P. D., Laird, D. W., et al. (2000). Clustering of connexin 43-enhanced green fluorescent protein gap junction channels and functional coupling in living cells. Proc. Natl. Acad. Sci. U.S.A. 97, 2556-2561. doi:10.1073/pnas.050588497.
4. Dhein, S. (2004). Pharmacology of gap junctions in the cardiovascular system. Cardiovasc. Res. 62, 287-298. doi:10.1016/j.cardiores.2004.01.019.
5. Dhein, S., Larsen, B. D., Petersen, J. S., and Mohr, F. W. (2003). Effects of the new antiarrhythmic peptide ZP123 on epicardial activation and repolarization pattern. Cell Commun. Adhes. 10, 371-378. doi:10.1080/cac.10.4-6.371.378.
6. Donahue, J. K., and Laurita, K. R. (2011). "Trachyarrhythmia therapies:approaches to atrial fibrillation and postinfarction ventricular arrhythmias," in Regenerating the Heart:Stem Cells and the Cardiovascular System, eds I. S. Cohen and G. Gaudette (New York, NY:Springer), 349-378.
7. Dovzhanskiy, D. I., Hartwig, W., Lazar, N. G., Schmidt, A., Felix, K., Straub, B. K., et al. (2012). Growth inhibition of pancreatic cancer by experimental treatment with 4-phenylbutyrate is associated with increased expression of connexin43. Oncol. Res. 20, 103-111. doi:10.3727/096504012X13477145152959.
8. Gemel, J., Valiunas, V., Brink, P., and Beyer, E. (2004). Connexin43 and connexin26 for gap junctions, but not heteromeric channels in co-expressing cells. J. Cell Sci. 117, 2469-2480. doi:10.1242/jcs.01084.
9. Hodgkin, A. L., and Huxley, A. F. (1952). A quantitative description of membrane current and its application to conduction and excitation in nerve. J. Physiol. 117, 500-544.
10. Jia, Z., Bien, H., Shiferaw, Y., and Entcheva, E. (2012). Cardiac cellular coupling and the spread of early instabilities in intracellular Ca2+. Biophys. J. 102, 1294-1302. doi:10.1016/j.bpj.2012.02.034.
11. Khan, Z., Akhtar, M., Asklund, T., Juliusson, B., Almqvist, P., and Ekstrom, T. (2007). HDAC inhibition amplifies gap junction communication in neural progenitors:potential for cell mediated enzyme prodrug therapy. Exp. Cell Res. 313, 2958-2967. doi:10.1016/j.yexcr.2007.05.004.
12. Pointis, G. (2006). Connexin43:emerging role in erectile function. Int. J. Biochem. Cell Biol. 38, 1642-1646. doi:10.1016/j.biocel.2006.03.007.
13. Rudy, Y. (2001). The ionic mechanisms of conduction in cardiac tissue. J. Electrocardiol. 34, 65-68. doi:10.1054/jelc.2001.28831.
14. Saffitz, J. E., Hames, K. Y., and Kanno, S. (2007). Remodeling of gap junctions in ischemic and nonischemic forms of heart disease. J. Membr. Biol. 218, 65-71. doi:10.1007/s00232-007-9031-2.
15. Sohl, G., and Willecke, K. (2004). Gap junctions and the connexin protein family. Cardiovasc. Res. 62, 228-232. doi:10.1016/j.cardiores.2003.11.013.
16. Valiunas, V., Beyer, E., and Brink, P. (2002). Cardiac gap junction channels show quantitative differences in selectivity. Circ. Res. 91, 104-111. doi:10.1161/01.RES.0000025638.24255.AA.
17. Valiunas, V., Gemel, J., Brink, P., and Beyer, E. (2001). Gap junction channels formed by coexpressed connexin40 and connexin43. Am. J. Physiol. Heart Circ. Physiol. 281, 1675-1689.
18. Valiunas, V., Mui, R., McLachlan, E., Valdimarsson, G., Brink, P., and White, T. (2004). Biophysical characterization of zebra fish connexin35 hemichannels. Am. J. Physiol. Cell Physiol. 287, 1596-1604. doi:10.1152/ajpcell.00225.2004.
19. Valiunas, V., Weingart, R., and Brink, P. (2000). Formation of heterotypic gap junction channels by connexins 40 and 43. Circ. Res. 86, 42-49. doi:10.1161/01.RES.86.2.e42.
20. Xing, D., Kjolbye, A., Nielsen, M., Petersen, J., Harlow, K., Rathlou, N., et al. (2003). ZP123 increases gap junctional conductance and prevents reentrant ventricular tachycardia during myocardial ischemia in open chest dogs. J. Cardiovasc. Electrophysiol. 14, 510-520. doi:10.1046/j.1540-8167.2003.02329.x.